Effect of citral and carvacrol on the susceptibility of Listeria monocytogenes and Listeria innocua to antibiotics.
The aim of this study was to evaluate the antibiotic susceptibility of Listeria innocua (L. innocua) and Listeria monocytogenes (L. monocytogenes) cells in the presence of citral and carvacrol at sublethal concentrations in an agar medium. The presence of terpenes in the L. monocytogenes and L. innocua culture medium provided a reduction in the minimal inhibitory concentration (MIC) of all the antibiotics tested. These effects were dependent on the concentration of terpenes present in the culture medium. The combination of citral and carvacrol potentiated antibiotic activity by reducing the MIC values of bacitracin and colistin from 32.0 and 128.0 μg ml⁻¹ to 1.0 and 2.0 μg ml⁻¹, respectively. Thus, both Listeria species became more susceptible to these drugs. In this way, the colistin and bacitracin resistance of L. monocytogenes and L. innocua was reversed in the presence of terpenes. Results obtained in this study show that the phytochemicals citral and carvacrol potentiate antibiotic activity, reducing the MIC values of cultured L. monocytogenes and L. innocua.


CONCLUSIONS
Phytochemicals citral and carvacrol potentiate antibiotic activity of erythromycin, bacitracin and colistin by reducing the MIC values of cultured Listeria monocytogenes and Listeria innocua. This effect in reducing the MIC values of the antibiotics tested in both micro-organisms was increased when natural antimicrobials were combined. This finding indicated that the combination among terpenes and antibiotic may contribute in reducing the required dosage of antibiotics due to the possible effect of terpenes on permeation barrier of the micro-organism cell membrane.
Department of Veterinary Medicine, CNPq Postdoctoral Fellowship, Espirito Santo Federal University, Alegre, Brazil.
S F
SF
Zanini
A B
AB
Silva-Angulo
A
A
Rosenthal
D
D
Rodrigo
A
A
Martínez
D000080462:Acyclic Monoterpenes; D000362:Agar / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001414:Bacitracin / Q000494:pharmacology*; D003091:Colistin / Q000494:pharmacology*; D000081007:Cymenes; D024881:Drug Resistance, Bacterial / Q000187:drug effects*; D008087:Listeria / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology; D008089:Listeria monocytogenes / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology; D008826:Microbial Sensitivity Tests; D039821:Monoterpenes / Q000494:pharmacology*
D000080462:Acyclic Monoterpenes; D000900:Anti-Bacterial Agents; D000081007:Cymenes; D039821:Monoterpenes; D001414:Bacitracin; D000362:Agar; C073316:carvacrol; C007076:citral; D003091:Colistin
Listeria innocua; Listeria monocytogenes; antibiotics; carvacrol; minimal inhibitory concentration